Literature DB >> 11222202

Hepatic perfusion parameters in chronic liver disease: dynamic CT measurements correlated with disease severity.

B E Van Beers1, I Leconte, R Materne, A M Smith, J Jamart, Y Horsmans.   

Abstract

OBJECTIVE: The aim of our study was to determine if hepatic perfusion parameters measured with CT change in relation to disease severity in patients with chronic liver disease. SUBJECTS AND METHODS: Dynamic contrast-enhanced single-section CT scans of the liver were obtained in 40 individuals who included six control subjects, 16 patients with noncirrhotic chronic liver disease, and 18 patients with cirrhosis. Hepatic, aortic, and portal venous time-density curves were fitted to a dual-input one-compartment model to calculate the liver perfusion, arterial fraction, distribution volume, and mean transit time.
RESULTS: Liver perfusion decreased in patients with cirrhosis (67 +/- 23 mL. min(-1). 100 mL(-1) versus 108 +/- 34 mL. min(-1). 100 mL(-1) in control subjects [p = 0.009] and 98 +/- 36 mL. min(-1). 100 mL(-1) in patients with noncirrhotic chronic liver disease [p = 0.003]), and the arterial fraction and the mean transit time increased (41 +/- 27% and 51 +/- 79 sec versus 17 +/- 16% and 16 +/- 5 sec in control subjects, and 19 +/- 6% and 17 +/- 8 sec in patients with noncirrhotic chronic liver disease [p < 0.05]). A significant correlation was seen between these three perfusion parameters and the severity of chronic liver disease based on clinical and biologic data (p < 0.001). No significant change in distribution volume was observed.
CONCLUSION: Hepatic perfusion parameters measured with CT were significantly altered in cirrhosis and correlated with the severity of chronic liver disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11222202     DOI: 10.2214/ajr.176.3.1760667

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  90 in total

1.  Targeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ari Partanen; Pavel S Yarmolenko; David Woods; Bradford J Wood; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2012       Impact factor: 3.914

2.  Mathematical spatio-temporal model of drug delivery from low temperature sensitive liposomes during radiofrequency tumour ablation.

Authors:  Astrid Gasselhuber; Matthew R Dreher; Ayele Negussie; Bradford J Wood; Frank Rattay; Dieter Haemmerich
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

3.  Perfusion CT findings in liver of patients with tumor during chemotherapy.

Authors:  Qing Zhang; Zhen-Guo Yuan; Dao-Qing Wang; Zhi-Hui Yan; Jun Tang; Zuo-Qin Liu
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

4.  Hepatic computed tomography perfusion: comparison of maximum slope and dual-input single-compartment methods.

Authors:  Tomonori Kanda; Takeshi Yoshikawa; Yoshiharu Ohno; Naoki Kanata; Hisanobu Koyama; Munenobu Nogami; Daisuke Takenaka; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2010-12-30       Impact factor: 2.374

5.  A semi-mechanistic model to predict the effects of liver cirrhosis on drug clearance.

Authors:  Trevor N Johnson; Koen Boussery; Karen Rowland-Yeo; Geoffrey T Tucker; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2010-03       Impact factor: 6.447

6.  Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis.

Authors:  Hideaki Takahashi; Ryuta Shigefuku; Yoshihito Yoshida; Hiroki Ikeda; Kotaro Matsunaga; Nobuyuki Matsumoto; Chiaki Okuse; Shigeru Sase; Fumio Itoh; Michihiro Suzuki
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 7.  Non-invasive diagnosis of advanced fibrosis and cirrhosis.

Authors:  Suraj Sharma; Korosh Khalili; Geoffrey Christopher Nguyen
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.

Authors:  Lin Zhai; Lan-Yan Qiu; Yuan Zu; Yan Yan; Xiao-Zhuan Ren; Jun-Feng Zhao; Yu-Jiang Liu; Ji-Bin Liu; Lin-Xue Qian
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  The use of perfusion CT for the evaluation of therapy combining AZD2171 with gefitinib in cancer patients.

Authors:  Martijn R Meijerink; Hester van Cruijsen; Klaas Hoekman; Matthijs Kater; Cors van Schaik; Jan Hein T M van Waesberghe; Giuseppe Giaccone; Radu A Manoliu
Journal:  Eur Radiol       Date:  2006-10-27       Impact factor: 5.315

10.  Kinetic analysis of FDG in rat liver: effect of dietary intervention on arterial and portal vein input.

Authors:  Sudheer D Rani; Samuel T Nemanich; Nicole Fettig; Kooresh I Shoghi
Journal:  Nucl Med Biol       Date:  2013-02-28       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.